Electroluminescent TCC, C3dg and fB/Bb epitope assays for profiling complement cascade activation in vitro using an activated complement serum calibration standard.
van Vuuren, BJ
Journal of Immunological Methods
NOTICE: this is the author’s version of a work that was accepted for publication in Journal of Immunological Methods. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Immunological Methods, Vol. 402, Iss. 1-2, pp. 50 – 56 doi:10.1016/j.jim.2013.11.010
Electroluminescent assays for epitopes on the complement components C3dg, terminal complement complex (TCC) and factor B/Bb (fB/Bb) have been developed with capture and detection antibodies to produce detection limits C3dg=91±9ng/mL, TCC=3±0.1ng/mL and fB=55.7±0.1ng/mL. The assay performance was assessed against a series of zymosan and heat aggregated IgG (HAIgG) in vitro activations of complement using a calibrated activated complement serum (ACS) as calibration standard. The ACS standard was stable within 20% accuracy over a 6-month period with freeze-thaw cycles as required. Differential activation of the complement cascade was observed for TCC showing a pseudo-first order formation half-life of 3.5h after activation with zymosan. The C3dg activation fragment indicates a 10% total activation for both activation agents. The kinetic-epitope analysis for fB indicates that the capture epitope is on the fB/Bb protein fragment which can then become covered by the formation of C3bBb or C3bBbP complexes during the time course of the cascade.
University of Exeter
Copyright © 2013 Elsevier B.V. All rights reserved.
Vol. 402, Iss. 1-2, pp. 50 - 56
Place of publication
Showing items related by title, author, creator and subject.
Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro Morad, HOJ; Belete, SC; Read, T; Shaw, AM (Elsevier for Association of Medical Laboratory Immunologists, 2015-09-21)An in vitro zymosan-activation of the Complement system, through the lectin and alternative pathways, was performed in pooled human serum over a 24h time-course. Activation was quantitatively monitored by measuring the ...
West, L; Lowman, DW; Mora-Montes, HM; Grubb, S; Murdoch, C; Thornhill, MH; Gow, NA; Williams, D; Haynes, K (American Society for Biochemistry and Molecular Biology, 2013-07-26)The fungus Candida glabrata is an important and increasingly common pathogen of humans, particularly in immunocompromised hosts. Despite this, little is known about the attributes that allow this organism to cause disease ...
Eichberger, Jürgen; Kelsey, David (Elsevier, 2002-10)We examine the effect of ambiguity in symmetric games with aggregate externalities. We find that ambiguity will increase/decrease the equilibrium strategy in games with strategic complements/substitutes and positive ...